ANGPTL3/Angiopoietin-like 3, His & Avi, Human
ANGPTL3/Angiopoietin-like 3, His & Avi, Human

ANGPTL3/Angiopoietin-like 3, His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.

ANGPTL3/Angiopoietin-like 3, His & Avi, Human

Human LILRB2 captured on Protein A chip, can bind ANGPTL3/Angiopoietin-like 3, His & Avi, Human, His Tag with an affinity constant of 17.6nM as determined in a SPR assay (Biacore T200).

ANGPTL3/Angiopoietin-like 3, His & Avi, Human

Immobilized ANGPTL3/Angiopoietin-like 3, His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-ANGPTL3 Antibody, hFc Tag with the EC50 of 42.3ng/ml determined by ELISA.

ANGPTL3/Angiopoietin-like 3, His & Avi, Human

ANGPTL3 is a secreted glycoprotein that is structurally related to the angiopoietins. Mature human ANGPTL3 contains an N-terminal coiled coil domain and a C‑terminal fibrinogen-like domain. ANGPTL3 is expressed in the liver from early in development through adulthood. Acts in part as a hepatokine that is involved in regulation of lipid and glucose metabolism. Proposed to play a role in the trafficking of energy substrates to either storage or oxidative tissues in response to food intake.
Z05021
¥55,963.00

Ask us a question
Product Introduction
Species Human
Protein Construction
ANGPTL3/Angiopoietin-like 3 (Ser17-Lys219)
Accession # Q9Y5C1		 His Avi
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 26.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 30-38 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • ANGPTL3/Angiopoietin-like 3, His & Avi, Human
    • ANGPTL3/Angiopoietin-like 3, His & Avi, Human

    ANGPTL3/Angiopoietin-like 3, His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.

  • ANGPTL3/Angiopoietin-like 3, His & Avi, Human
    • ANGPTL3/Angiopoietin-like 3, His & Avi, Human

    Human LILRB2 captured on Protein A chip, can bind ANGPTL3/Angiopoietin-like 3, His & Avi, Human, His Tag with an affinity constant of 17.6nM as determined in a SPR assay (Biacore T200).

  • ANGPTL3/Angiopoietin-like 3, His & Avi, Human
    • ANGPTL3/Angiopoietin-like 3, His & Avi, Human

    Immobilized ANGPTL3/Angiopoietin-like 3, His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-ANGPTL3 Antibody, hFc Tag with the EC50 of 42.3ng/ml determined by ELISA.


Background
Target Background ANGPTL3 is a secreted glycoprotein that is structurally related to the angiopoietins. Mature human ANGPTL3 contains an N-terminal coiled coil domain and a C‑terminal fibrinogen-like domain. ANGPTL3 is expressed in the liver from early in development through adulthood. Acts in part as a hepatokine that is involved in regulation of lipid and glucose metabolism. Proposed to play a role in the trafficking of energy substrates to either storage or oxidative tissues in response to food intake.
Synonyms ANGPTL3; ANGPT5; ANG-5; Angiopoietin-5; FHBL2; ANL3; Angiopoietin-5; Angiopoietin-like Protein 3

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.